Manufacturing Partnership With Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski
Business Of Biotech
Intro
This chapter explores the partnership between Life Biosciences and Forge Biologics in the development of a partial epigenetic reprogramming therapy. It underscores the significance of choosing the right contract development and manufacturing organization (CDMO) while providing insights into Forge Biologics' strategic growth in the cell and gene therapy industry.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
